Literature DB >> 9446567

Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom.

A Koschak1, R M Bugianesi, J Mitterdorfer, G J Kaczorowski, M L Garcia, H G Knaus.   

Abstract

Five novel peptidyl inhibitors of Shaker-type (Kv1) K+ channels have been purified to homogeneity from venom of the scorpion Centruroides limbatus. The complete primary amino acid sequence of the major component, hongotoxin-1 (HgTX1), has been determined and confirmed after expression of the peptide in Escherichia coli. HgTX1 inhibits 125I-margatoxin binding to rat brain membranes as well as depolarization-induced 86Rb+ flux through homotetrameric Kv1.1, Kv1. 2, and Kv1.3 channels stably transfected in HEK-293 cells, but it displays much lower affinity for Kv1.6 channels. A HgTX1 double mutant (HgTX1-A19Y/Y37F) was constructed to allow high specific activity iodination of the peptide. HgTX1-A19Y/Y37F and monoiodinated HgTX1-A19Y/Y37F are equally potent in inhibiting 125I-margatoxin binding to rat brain membranes as HgTX1 (IC50 values approximately 0.3 pM). 125I-HgTX1-A19Y/Y37F binds with subpicomolar affinities to membranes derived from HEK-293 cells expressing homotetrameric Kv1.1, Kv1.2, and Kv1.3 channels and to rat brain membranes (Kd values 0.1-0.25 pM, respectively) but with lower affinity to Kv1.6 channels (Kd 9.6 pM), and it does not interact with either Kv1.4 or Kv1.5 channels. Several subpopulations of native Kv1 subunit oligomers that contribute to the rat brain HgTX1 receptor have been deduced by immunoprecipitation experiments using antibodies specific for Kv1 subunits. HgTX1 represents a novel and useful tool with which to investigate subclasses of voltage-gated K+ channels and Kv1 subunit assembly in different tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9446567     DOI: 10.1074/jbc.273.5.2639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Authors:  D C Hanson; A Nguyen; R J Mather; H Rauer; K Koch; L E Burgess; J P Rizzi; C B Donovan; M J Bruns; P C Canniff; A C Cunningham; K A Verdries; E Mena; J C Kath; G A Gutman; M D Cahalan; S Grissmer; K G Chandy
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 2.  Molecular properties and physiological roles of ion channels in the immune system.

Authors:  M D Cahalan; H Wulff; K G Chandy
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

3.  Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease.

Authors:  Souvarish Sarkar; Hai M Nguyen; Emir Malovic; Jie Luo; Monica Langley; Bharathi N Palanisamy; Neeraj Singh; Sireesha Manne; Matthew Neal; Michelle Gabrielle; Ahmed Abdalla; Poojya Anantharam; Dharmin Rokad; Nikhil Panicker; Vikrant Singh; Muhammet Ay; Adhithiya Charli; Dilshan Harischandra; Lee-Way Jin; Huajun Jin; Srikant Rangaraju; Vellareddy Anantharam; Heike Wulff; Anumantha G Kanthasamy
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

4.  A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.

Authors:  Kamilla Angelo; Yuliya V Korolkova; Morten Grunnet; Eugene V Grishin; Kirill A Pluzhnikov; Dan A Klaerke; Hans-Günther Knaus; Morten Møller; Søren-Peter Olesen
Journal:  Pflugers Arch       Date:  2003-08-05       Impact factor: 3.657

5.  Two heteromeric Kv1 potassium channels differentially regulate action potential firing.

Authors:  Paul D Dodson; Matthew C Barker; Ian D Forsythe
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

6.  Protein surface recognition by rational design: nanomolar ligands for potassium channels.

Authors:  Stefan N Gradl; John P Felix; Ehud Y Isacoff; Maria L Garcia; Dirk Trauner
Journal:  J Am Chem Soc       Date:  2003-10-22       Impact factor: 15.419

7.  Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.

Authors:  Zoltan Varga; Georgina Gurrola-Briones; Ferenc Papp; Ricardo C Rodríguez de la Vega; Gustavo Pedraza-Alva; Rajeev B Tajhya; Rezso Gaspar; Luis Cardenas; Yvonne Rosenstein; Christine Beeton; Lourival D Possani; Gyorgy Panyi
Journal:  Mol Pharmacol       Date:  2012-05-23       Impact factor: 4.436

8.  Structural and functional consequences of the presence of a fourth disulfide bridge in the scorpion short toxins: solution structure of the potassium channel inhibitor HsTX1.

Authors:  P Savarin; R Romi-Lebrun; S Zinn-Justin; B Lebrun; T Nakajima; B Gilquin; A Menez
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

9.  Biophysical and pharmacological properties of the voltage-gated potassium current of human pancreatic beta-cells.

Authors:  James Herrington; Manuel Sanchez; Denize Wunderler; Lizhen Yan; Randal M Bugianesi; Ivy E Dick; Sam A Clark; Richard M Brochu; Birgit T Priest; Martin G Kohler; Owen B McManus
Journal:  J Physiol       Date:  2005-06-02       Impact factor: 5.182

10.  KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.

Authors:  Morten Grunnet; Hannne B Rasmussen; Anders Hay-Schmidt; Maiken Rosenstierne; Dan A Klaerke; Søren-Peter Olesen; Thomas Jespersen
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.